These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 39417290)

  • 1. Translational research priorities for bacteriophage therapeutics.
    Schooley RT
    Essays Biochem; 2024 Oct; ():. PubMed ID: 39417290
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Towards promising antimicrobial alternatives: The future of bacteriophage research and development in Saudi Arabia.
    Alsaadi A; Imam M; Alghamdi AA; Alghoribi MF
    J Infect Public Health; 2022 Dec; 15(12):1355-1362. PubMed ID: 36332378
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Phage Therapy in the Resistance Era: Where Do We Stand and Where Are We Going?
    Luong T; Salabarria AC; Roach DR
    Clin Ther; 2020 Sep; 42(9):1659-1680. PubMed ID: 32883528
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Phage steering of antibiotic-resistance evolution in the bacterial pathogen,
    Gurney J; Pradier L; Griffin JS; Gougat-Barbera C; Chan BK; Turner PE; Kaltz O; Hochberg ME
    Evol Med Public Health; 2020; 2020(1):148-157. PubMed ID: 34254028
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A Phage Foundry Framework to Systematically Develop Viral Countermeasures to Combat Antibiotic-Resistant Bacterial Pathogens.
    Mutalik VK; Arkin AP
    iScience; 2022 Apr; 25(4):104121. PubMed ID: 35402883
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Phage therapeutics: from promises to practices and prospectives.
    Bhargava K; Nath G; Bhargava A; Aseri GK; Jain N
    Appl Microbiol Biotechnol; 2021 Dec; 105(24):9047-9067. PubMed ID: 34821965
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bacteriophage therapy against ESKAPE bacterial pathogens: Current status, strategies, challenges, and future scope.
    Kulshrestha M; Tiwari M; Tiwari V
    Microb Pathog; 2024 Jan; 186():106467. PubMed ID: 38036110
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bacteriophage Therapeutics: A Primer for Clinicians on Phage-Antibiotic Combinations.
    Morrisette T; Kebriaei R; Lev KL; Morales S; Rybak MJ
    Pharmacotherapy; 2020 Feb; 40(2):153-168. PubMed ID: 31872889
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Phage-inspired strategies to combat antibacterial resistance.
    Wang M; Zhang J; Wei J; Jiang L; Jiang L; Sun Y; Zeng Z; Wang Z
    Crit Rev Microbiol; 2024 Mar; 50(2):196-211. PubMed ID: 38400715
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of regulated clinical trials in the development of bacteriophage therapeutics.
    Parracho HM; Burrowes BH; Enright MC; McConville ML; Harper DR
    J Mol Genet Med; 2012; 6():279-86. PubMed ID: 22872803
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bacteriophage steering of
    Ruest MK; Supina BSI; Dennis JJ
    J Bacteriol; 2023 Oct; 205(10):e0019623. PubMed ID: 37791751
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bacteriophage therapy- a refurbished age-old potential strategy to treat antibiotic and multidrug resistant bacterial infections in future.
    Dave R; Banerjee D
    Braz J Microbiol; 2024 Sep; 55(3):3043-3049. PubMed ID: 38951476
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Basic Guidelines for Bacteriophage Isolation and Characterization.
    Samir S
    Recent Pat Biotechnol; 2023; 17(4):312-331. PubMed ID: 36263478
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diverse Durham collection phages demonstrate complex BREX defense responses.
    Kelly A; Went SC; Mariano G; Shaw LP; Picton DM; Duffner SJ; Coates I; Herdman-Grant R; Gordeeva J; Drobiazko A; Isaev A; Lee YJ; Luyten Y; Morgan RD; Weigele P; Severinov K; Wenner N; Hinton JCD; Blower TR
    Appl Environ Microbiol; 2023 Sep; 89(9):e0062323. PubMed ID: 37668405
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Component Parts of Bacteriophage Virions Accurately Defined by a Machine-Learning Approach Built on Evolutionary Features.
    Thung TY; White ME; Dai W; Wilksch JJ; Bamert RS; Rocker A; Stubenrauch CJ; Williams D; Huang C; Schittelhelm R; Barr JJ; Jameson E; McGowan S; Zhang Y; Wang J; Dunstan RA; Lithgow T
    mSystems; 2021 Jun; 6(3):e0024221. PubMed ID: 34042467
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Phage Therapy for Antibiotic-Resistant Bacterial Infections.
    Hatfull GF; Dedrick RM; Schooley RT
    Annu Rev Med; 2022 Jan; 73():197-211. PubMed ID: 34428079
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Building Better Bacteriophage with Biofoundries to Combat Antibiotic-Resistant Bacteria.
    Weynberg KD; Jaschke PR
    Phage (New Rochelle); 2020 Mar; 1(1):23-26. PubMed ID: 36147618
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The current status of phage therapy and its advancement towards establishing standard antimicrobials for combating multi drug-resistant bacterial pathogens.
    Ali Y; Inusa I; Sanghvi G; Mandaliya VB; Bishoyi AK
    Microb Pathog; 2023 Aug; 181():106199. PubMed ID: 37336428
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Viruses versus bacteria-novel approaches to phage therapy as a tool against multidrug-resistant pathogens.
    Viertel TM; Ritter K; Horz HP
    J Antimicrob Chemother; 2014 Sep; 69(9):2326-36. PubMed ID: 24872344
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhaled Bacteriophage Therapy for Multi-Drug Resistant
    Winzig F; Gandhi S; Lee A; Würstle S; Stanley GL; Capuano I; Neuringer I; Koff JL; Turner PE; Chan BK
    Yale J Biol Med; 2022 Dec; 95(4):413-427. PubMed ID: 36568830
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.